Dec 4, 2025

Featuring an interview with Dr Matthew Lunning, including the following topics:

• Reflection on the advances made in chimeric antigen receptor (CAR) T-cell therapy (0:00)
• Overview of the CAR T-cell therapy administration process (4:40)
• Opportunities for referral for CAR T-cell therapy (10:05)
• Selection of a CAR T-cell...

Dec 4, 2025

Featuring a slide presentation and related discussion from Dr Matthew Lunning, including the following topics:

• Overview of available chimeric antigen receptor (CAR) T-cell therapies (0:00)
• Toxicities associated with CAR T-cell therapy (4:03)
• Mitigation strategies for adverse events (22:02)
• Novel strategies for...

Dec 2, 2025

Featuring an interview with Dr Priyanka Sharma, including the following topics:

• Patient-reported outcomes from the SERENA-6 trial of camizestrant with a CDK4/6 inhibitor for patients with HR-positive, HER2-negative advanced breast cancer and ESR1 mutations emerging during first-line endocrine-based therapy...

Nov 29, 2025

Featuring perspectives from Dr Komal Jhaveri and Dr Virginia Kaklamani, including the following topics: 

• Introduction: Oral Selective Estrogen Receptor Degraders (SERDs) for the General Medical Oncologist (0:00)
• SERD Monotherapy (13:34)
• SERD and CDK Inhibitor Combination — The EMBER-3 Study (35:58)
• SERDs for...

Nov 26, 2025

Featuring an interview with Dr Priyanka Sharma, including the following topics:

• T-DXd versus trastuzumab emtansine for high-risk HER2-positive primary breast cancer with residual invasive disease after neoadjuvant therapy: Interim analysis of the DESTINY-Breast05 trial (0:00)
  • Geyer C...